Document Detail


Mini review: immune response to myelin-derived sulfatide and CNS-demyelination.
MedLine Citation:
PMID:  17006761     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Here we briefly review our understanding of the immune response to myelin-derived glycolipids during an inflammatory autoimmune response in the central nervous system (CNS). We focus primarily on the recognition of the self-glycolipid sulfatide by a distinct population of non-invariant NK T cells. The results of studies we have obtained so far in investigating the presentation of sulfatide by CNS-resident cells including microglia and their interactions with T cells indicate that this pathway might be successfully targeted for the treatment of autoimmune demyelination in multiple sclerosis.
Authors:
Ramesh C Halder; A Jahng; I Maricic; Vipin Kumar
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review     Date:  2006-09-28
Journal Detail:
Title:  Neurochemical research     Volume:  32     ISSN:  0364-3190     ISO Abbreviation:  Neurochem. Res.     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-02-08     Completed Date:  2007-03-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7613461     Medline TA:  Neurochem Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  257-62     Citation Subset:  IM    
Affiliation:
Laboratory of Autoimmunity, Torrey Pines Institute for Molecular Studies, 3550 General Atomics Court, San Diego, CA 92121, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antigens, CD1 / physiology
Demyelinating Autoimmune Diseases, CNS / immunology*
Encephalomyelitis, Autoimmune, Experimental / immunology
Galactosylceramides / immunology
Glycolipids / immunology
Humans
Killer Cells, Natural / immunology
Mice
Multiple Sclerosis / immunology
Sulfoglycosphingolipids / immunology*
T-Lymphocytes / immunology
Chemical
Reg. No./Substance:
0/Antigens, CD1; 0/Galactosylceramides; 0/Glycolipids; 0/Sulfoglycosphingolipids; 0/alpha-galactosylceramide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased expression of p130 in Alzheimer disease.
Next Document:  Kinetic parameters and lactate dehydrogenase isozyme activities support possible lactate utilization...